Welcome : Guest

Sorrento Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sorrento Therapeutics, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 46 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-65400
Price: $2300
Company Type: Public
Pages: 48
Date: April 2016
Market Data Tables: 46

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......2
Table 1: Biopharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......2
Biologics......3
Table 2: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......3
Table 3: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......4
Table 4: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......5
Table 5: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......6
Table 6: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......7
Biosimilars......8
Table 7: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......8
Injectables......9
Table 8: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......9
Table 9: Injectables Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......10
Cancer Drugs......11
Table 10: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......11
Table 11: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......12
Table 12: Cancer-Associated Mucositis Market by Activity Worldwide (2015) – Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......13
Table 13: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......14
Table 14: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......15
Table 15: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......16
Table 16: Standard Injectables Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Infectives, Blood, Oncology and Others......17
Table 17: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......18
Table 18: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......19
Table 19: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......20
Table 20: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, CCV, Digest, Neurology, Oncology and Others......21
Oncology Drugs......22
Table 21: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......22
Table 22: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......23
Table 23: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......24
Table 24: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......25
Table 25: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......26
Table 26: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......27
Table 27: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......28
Table 28: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......29
Table 29: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......30
Immunotherapy......31
Table 30: Allergy Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, France, Germany, Italy, Spain and Others......31
Table 31: Immunotherapy Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Sublingual, and Subcutaneous......32
Table 32: No. of Patients for Immunotherapy by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, North America, and Others......33
Table 33: No. of Patients for Immunotherapy by Age Group in the US (2015) - Percentage Market Share Breakdown by Value for 0-4 Patient Pool, 10 - 14 Patient Pool, 15 - 19 Patient Pool, 5-9 Patient Pool, Adult Patient Pool (over 65), and Adult Patient Pool (under 65)......34
Table 34: Grass Allergy Immunotherapy Treatment by Segment in Germany (2015) - Percentage Breakdown by No. of Patients for Subcutaneous, Sublingual, and Tablet......35
Table 35: Grass Allergy Immunotherapy Treatment by Type in Germany (2015) - Percentage Breakdown by No. of New Patients for Subcutaneous, and Sublingual......36
Biopharmaceuticals......37
Table 36: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......37
Biosimilars......38
Table 37: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015) - Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......38
Cancer Drugs......39
Table 38: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......39
Table 39: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......40
Table 40: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......41
Table 41: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......42
Table 42: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......43
Oncology Drugs......44
Table 43: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......44
Table 44: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......45
Immunotherapy Products......46
Table 45: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......46
Table 46: Market Shares of Leading Bulk Extract Allergy Immunotherapy Manufacturers in the US (2015) - Percentage Breakdown by Value for ALK, Greer Laboratories, Inc., HollisterStier LLC and Others......47